CME Articles

Managing Bone Disease in  Kidney Transplant Recipients

By Miklos Z. Molnar, MD, PhD, and Kamyar Kalantar-Zadeh, MD, MPH, PhD May 01, 2012

Pre-existing renal osteodystrophy at the time of transplantation, reduced renal  function, and transplantation-specific therapies are the main contributing factors.

Assessment and Diagnostic Strategies for Neurogenic Bladder: Part I

By David A. Ginsberg, MD May 01, 2012

Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients

Part II: Clinical Challenges and Renal Considerations in Managing Gout

By James W. Lohr, MD April 01, 2012

A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.

Clinical Challenges and Renal Considerations In Managing Gout

By William F. Finn, MD March 01, 2012

A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.

The Management of Patients After Renal Transplantation

By Daniel C. Brennan, MD, FACP February 01, 2012

Patients who undergo renal transplantation require complex care that involves a diligent, multidisciplinary approach.

An Update on Robotic-Assisted Partial Nephrectomy

By Rosalia Viterbo, MD January 01, 2012

Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors.

A Nephrologic Perspective on the Management of Gout

By Anthony J. Bleyer, MD December 01, 2011

Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well-studied in this patient group.

Examining the Pharmacoeconomics of Advanced Prostate Cancer

By Daniel P. Petrylak, MD November 01, 2011

In determining prostate cancer treatment, physicians should discuss preferences, values, and expectations with patients, including life expectancy, adverse events, and costs

Hyponatremia: An Update on the Management of SIADH

By Mitchell H. Rosner, MD, FACP October 01, 2011

Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists

Intermittent ADT in Prostate Cancer: A Step-by-Step Approach

By Leonard G. Gomella, MD, FACS September 01, 2011

In select patients, use of intermittent therapy does not appear to negatively affect overall survival and is associated with fewer adverse events.

Prostatitis and Chronic Pelvic Pain Syndrome: An Update

By Naji J. Touma, MD, FRCS(C) and J. Curtis Nickel, MD, FRCS(C) August 01, 2011

Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.

Cause-Specific Outcomes Associated with Hypovitaminosis D

By Csaba P. Kovesdy, MD July 01, 2011

The complex biological actions of vitamin D suggest its involvement in various pathologies. (This is the second of a two-part CME article.)

Vitamin D and Clinical Outcomes in Patients With and Without CKD: Part I

By Csaba P. Kovesdy, MD June 01, 2011

Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality.

Relationships of Testosterone and Prostate Cancer: A 2011 Perspective

By Kelly Chiles, MD and Stanton Honig, MD May 01, 2011

A history of prostate cancer has generally been a contraindication for testosterone therapy, but the clinical model may be changing.

IgA Nephropathy: An Update on Diagnosis and Management

By Richard J. Glassock, MD, MACP April 01, 2011

Following a renal biopsy diagnosis of IgA nephropathy, clinicians need to estimate prognosis and design an appropriate short- and long-term treatment strategy.

Classifying Histologic Subtypes of Renal Cell Carcinoma

By Lara R. Harik, MD and Maria Alexandra Ordoñez, MD March 01, 2011

Recent advances in understanding genetic changes associated with kidney tumor  formation have led to new pathologic classifications.

Managing Patients Following a Negative Prostate Biopsy

By J. Stephen Jones, MD, FACS February 01, 2011

This article addresses the issues that must be understood to navigate the scenario posed by patients that have had a prior negative biopsy.

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

By Orlando M. Gutiérrez, MD January 01, 2011

The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. Key to these efforts is the availability of clinically accessible biomarkers that can help distinguish between a wide variety of bone and mineral disturbances related to kidney failure.

Post-Test

Once you have read the CME article, click on the link at the beginning of each article to take the post-test. To view the full RUN myCME page, click here.

CME SPOTLIGHT

Prostatitis and Chronic Pelvic Pain Syndrome: An Update
1.00 / AMA PRA Category 1 Credit(s)™ Click here for more courses

Current Poll

Has a radiologist ever challenged one of your orders for an imaging procedure?

Click here to take the poll

May Issue

Click here to read issue articles.
Flip through our digital issue.

Cartoons

Click here for our latest cartoons

Clinical Quiz

Small Renal Masses and Drug-Eluting Stents — How to Best Balance the Risks?

A 55-year-old male with significant history of coronary artery disease is found to have an intraparenchymal 2 cm left-enhancing small renal mass. Answer the quiz correctly and you'll have a chance to win an American Express gift card.